Drawing for HEALTHIVERSE

USPTO serial 88546593

HEALTHIVERSE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SABLE, ERIC
Law office
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HEALTHIVERSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa Peller London

Lisa Peller London BELLES KATZ LLC1800 John F. Kennedy Blvd.Suite 1010Philadelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
009Recorded computer software for use in the healthcare industry to allow for the transferring of electronic messages, data and medical information, namely, patient information, on a one-to-one or one-to-many users basisACTIVE—
035Health care business services, namely, management and compilation of a computer database for use in selection of potential patients for conducting medical research projects and for conducting patient surveys by third party pharmaceutical and medical companies; Business consulting and management in the field of clinical drug trials, namely, providing information management services relating to the notification of potential patients and patients regarding participation in medical drug trials, medical evaluation and feedback from patients regarding prescription drug usage and other issues relating to medical research programs; providing electronic prescription refill services and prescription processing services, namely, processing prescription orders in retail and central fill pharmacies; Providing electronic prescription refill and prescription processing services, namely, providing prescription refills to pharmacies from physicians' offices for others to facilitate online prescription management, all for business purposes; providing office business management services for medical practices and practitioners, namely, preparing business reports and business advice in the field of budgeting, via the Internet, telephone, fax, and mailACTIVE—
036Financial advice, namely, budget planningACTIVE—
042Providing temporary use of online non-downloadable software for use in medical services, namely, for generating medical prescriptions and recording patient information; software as a service (SAAS) services featuring software for use in the healthcare industry for electronic prescribing of controlled substances; software as a service (SAAS) services featuring software for use in the healthcare industry to allow for the transferring of electronic messages, data and medical information, namely, patient information, on a one-to-one or one-to-many users basis; software as a service (SAAS) services featuring software for use in the healthcare services industry to allow authorized individuals to access, share and exchange medical information, namely, prescription and patient information and messages pertaining to such medical information; software as a service (SAAS) services featuring software that allows for the secure exchange of medical prescriptions and patient and medical information; application service provider services featuring software and secure communications software in the field of healthcare management and clinical management via the Internet, intranets or global communications or information networks for use by medical/health services providers, namely, providing software for prescription handling services, namely, electronic prescription handling and for secure electronic transmission services, namely, for providing secure email transmissions and secure transmissions of electronic medical records, clinical patient data and other private information; computer software installation and maintenance; design, hosting, and maintenance of public and private Internet sites for medical/health service providersACTIVE—
044Providing online medical information in the field of patient medical record and prescription information; providing electronic prescription refill reminder services and electronic medication refill reminder services to healthcare providersACTIVEFeb 20, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 27, 2021MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 27, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 16, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2021CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 20, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 29, 2021IUAFUSE AMENDMENT FILED—
Jan 29, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 4, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 9, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 9, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 20, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 30, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 29, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2019DOCKASSIGNED TO EXAMINER—
Aug 8, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance